Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003266 citationsJournal Article

Authors

Grant R. Goodman · Scripps Research Institute

Carol Burian · Scripps Research Institute

James A. Koziol · Scripps Research Institute

Abstract

These results confirm previous observations that single courses of cladribine administered to patients with HCL induce high response rates, the majority of which are CRs. Most patients enjoy long-lasting complete remissions, and those patients who experience relapse can be successfully re-treated with cladribine.

Topics & Keywords

Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Toxin Mechanisms and Immunotoxins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 21, Issue 5, pp. 891-896

DOI: 10.1200/jco.2003.05.093

Field-Weighted Citation Impact: 7.46